Where Does Aerpio Pharmaceuticals Inc (ARPO) Stock Fall in the Biotechnology Field After It Is Up 3.01% This Week? – InvestorsObserver

Aerpio Pharmaceuticals Inc (ARPO) is near the top in its industry group according to InvestorsObserver. ARPO gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Aerpio Pharmaceuticals Inc gets a 96 rank in the Biotechnology industry. Biotechnology is number 111 out of 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Aerpio Pharmaceuticals Inc (ARPO) stock is lower by -15.35% while the S&P 500 has risen 1.15% as of 1:43 PM on Monday, May 24. ARPO is down -$0.31 from the previous closing price of $2.02 on volume of 3,709,381 shares. Over the past year the S&P 500 is up 40.50% while ARPO has risen 116.46%. ARPO lost -$0.08 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Aerpio Pharmaceuticals Inc (ARPO) Stock.

Follow this link:
Where Does Aerpio Pharmaceuticals Inc (ARPO) Stock Fall in the Biotechnology Field After It Is Up 3.01% This Week? - InvestorsObserver